We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEI
2401
Solaris Energy Infrastructure
SEI
$3.82B
| $2.08M | ﹤0.01% |
148,613
+6,936
| +5% | +$83.4K |
|
2402
Cue Biopharma
CUE
$114M
| $2.08M | ﹤0.01% |
4,359
+2,027
| +87% | +$637K |
|
2403
Waterstone Financial
WSBF
$375M
| $2.08M | ﹤0.01% |
109,115
-503
| -0.5% | -$9.26K |
|
2404
nLIGHT
LASR
$3.17B
| $2.07M | ﹤0.01% |
101,942
-3,233
| -3% | -$55.7K |
|
2405
Precision BioSciences
DTIL
$207M
| $2.06M | ﹤0.01% |
4,953
+4,500
| +993% | +$1.41M |
|
2406
Movado Group
MOV
$841M
| $2.05M | ﹤0.01% |
94,336
-5,434
| -5% | -$127K |
|
2407
Civista Bancshares
CIVB
$589M
| $2.05M | ﹤0.01% |
85,259
-3,852
| -4% | -$85.5K |
|
2408
HDFC Bank
HDB
$121B
| $2.05M | ﹤0.01% |
64,576
-1,994
| -3% | -$60.7K |
|
2409
Viking Therapeutics
VKTX
$4B
| $2.04M | ﹤0.01% |
254,959
-167,442
| -40% | -$1.22M |
|
2410
Monarch Casino & Resort
MCRI
$2.23B
| $2.04M | ﹤0.01% |
42,055
-1,467
| -3% | -$65.2K |
|
|
BCOV
2411
DELISTED
Brightcove, Inc.
BCOV
| $2.03M | ﹤0.01% |
233,551
+7,480
| +3% | +$70.2K |
|
|
JCP
2412
DELISTED
J.C. Penney Company, Inc.
JCP
| $2.03M | ﹤0.01% |
1,809,920
+566,470
| +46% | +$602K |
|
|
TPC
2413
Tutor Perini Cor
TPC
$5.21B
| $2.03M | ﹤0.01% |
157,582
-576
| -0.4% | -$8.88K |
|
|
PRMW
2414
DELISTED
Primo Water Corporation
PRMW
| $2.03M | ﹤0.01% |
180,495
-1,946,502
| -92% | -$21.6M |
|
2415
Westwood Holdings Group
WHG
$190M
| $2.01M | ﹤0.01% |
67,824
-6,002
| -8% | -$178K |
|
|
PETQ
2416
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $2M | ﹤0.01% |
79,831
+2,415
| +3% | +$60K |
|
|
GRFS
2417
Grifois
GRFS
$5.4B
| $2M | ﹤0.01% |
85,720
-1,171
| -1% | -$25.5K |
|
2418
Mesa Laboratories
MLAB
$574M
| $1.99M | ﹤0.01% |
7,996
-6,149
| -43% | -$1.44M |
|
2419
Alector
ALEC
$199M
| $1.99M | ﹤0.01% |
115,463
-3,654
| -3% | -$62.1K |
|
2420
National CineMedia
NCMI
$378M
| $1.97M | ﹤0.01% |
27,077
-681
| -2% | -$51.3K |
|
2421
SI-BONE Inc
SIBN
$834M
| $1.97M | ﹤0.01% |
91,702
| – | – |
|
|
CMRX
2422
DELISTED
Chimerix, Inc.
CMRX
| $1.95M | ﹤0.01% |
961,041
+128,760
| +15% | +$237K |
|
|
ZIXI
2423
DELISTED
Zix Corporation
ZIXI
| $1.94M | ﹤0.01% |
286,836
+78,133
| +37% | +$540K |
|
2424
Mercado Libre
MELI
$92.3B
| $1.94M | ﹤0.01% |
3,398
+643
| +23% | +$356K |
|
2425
CRISPR Therapeutics
CRSP
$5.17B
| $1.94M | ﹤0.01% |
31,821
-495
| -2% | -$27K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.